Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
April 1, 1995
Post-capillary venules in the "milky spots" of the greater omentum are the major site of plasma protein and leukocyte extravasation in rodent models of peritonitis
N S Doherty, R J Griffiths, J P Hakkinen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
August 18, 2001
Induction of hepatic microsomal drug-metabolizing enzymes by inhibitors of 5-lipoxygenase (5-LO): studies in rats and 5-LO knockout mice
W P Beierschmitt, J D McNeish, R J Griffiths, et al.
British Journal of Pharmacology
|
April 1, 1996
Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram
E R Pettipher, J M Labasi, E D Salter, et al.
Agents and Actions
|
June 1, 1990
FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor
A Blackham, R J Griffiths, C Hallam, et al.
Chemical Science
|
May 3, 2018
Oxidative β-C-H sulfonylation of cyclic amines
R J Griffiths, W C Kong, S A Richards, et al.
The Journal of Biological Chemistry
|
October 4, 2000
Altered cytokine production in mice lacking P2X(7) receptors
M Solle, J Labasi, D G Perregaux, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1997
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy
J B Cheng, J W Watson, C J Pazoles, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 17, 1995
Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis
R J Griffiths, E R Pettipher, K Koch, et al.
Journal of Medicinal Chemistry
|
September 30, 1994
(+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis model
K Koch, L S Melvin, L A Reiter, et al.
The Journal of Experimental Medicine
|
March 17, 1997
Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice
R J Griffiths, M A Smith, M L Roach, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
April 1, 1995
Post-capillary venules in the "milky spots" of the greater omentum are the major site of plasma protein and leukocyte extravasation in rodent models of peritonitis
N S Doherty, R J Griffiths, J P Hakkinen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
August 18, 2001
Induction of hepatic microsomal drug-metabolizing enzymes by inhibitors of 5-lipoxygenase (5-LO): studies in rats and 5-LO knockout mice
W P Beierschmitt, J D McNeish, R J Griffiths, et al.
British Journal of Pharmacology
|
April 1, 1996
Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram
E R Pettipher, J M Labasi, E D Salter, et al.
Agents and Actions
|
June 1, 1990
FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor
A Blackham, R J Griffiths, C Hallam, et al.
Chemical Science
|
May 3, 2018
Oxidative β-C-H sulfonylation of cyclic amines
R J Griffiths, W C Kong, S A Richards, et al.
The Journal of Biological Chemistry
|
October 4, 2000
Altered cytokine production in mice lacking P2X(7) receptors
M Solle, J Labasi, D G Perregaux, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1997
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy
J B Cheng, J W Watson, C J Pazoles, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 17, 1995
Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis
R J Griffiths, E R Pettipher, K Koch, et al.
Journal of Medicinal Chemistry
|
September 30, 1994
(+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis model
K Koch, L S Melvin, L A Reiter, et al.
The Journal of Experimental Medicine
|
March 17, 1997
Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice
R J Griffiths, M A Smith, M L Roach, et al.
Page
of 6